Literature DB >> 33892152

Local and Systemic Expression Pattern of MMP-2 and MMP-9 in Complex Regional Pain Syndrome.

Fabiola Escolano-Lozano1, Eva Gries2, Tanja Schlereth3, Violeta Dimova4, Panoraia Baka4, Eva Vlckova5, Simone König6, Frank Birklein4.   

Abstract

Matrix metalloproteinases (MMP)-2 and MMP-9 play important roles in inflammation as well as in pain processes. For this reason, we compared the concentrations of these enzymes in skin and serum of patients with complex regional pain syndrome (CRPS), other pain diseases and healthy subjects. We analyzed ipsi- and contralateral skin biopsies of 18 CRPS patients, as well as in 10 pain controls and 9 healthy subjects. Serum samples were analyzed from 20 CRPS, 17 pain controls and 17 healthy subjects. All samples were analyzed with ELISA. Concentrations were then compared to clinical data as well as to quantitative sensory testing data.MMP-2 was increased in both ipsi- and contralateral skin biopsies of CRPS patients compared to healthy subjects. While low ipsilateral MMP-2 was associated with trophic changes, contralateral MMP-2 inversely correlated with the CRPS severity. MMP-9 was also locally increased in ipsilateral CRPS skin, and higher ipsi- and contralateral MMP-9 levels correlated with CRPS severity. We conclude that MMP-2 and MMP-9 are differently expressed depending on the clinical phenotype in CRPS. PERSPECTIVE: This article describes an upregulation of MMPs in CRPS and pain controls and shows different expression of MMP-2 and -9 depending on clinical phenotype in CRPS. These results provide evidence that MMP-2 and -9 play a key role in CRPS pathophysiology.
Copyright © 2021 United States Association for the Study of Pain, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complex regional pain syndrome; Complex regional pain syndrome severity score; inflammation; matrix metalloproteinases; pain

Mesh:

Substances:

Year:  2021        PMID: 33892152     DOI: 10.1016/j.jpain.2021.04.002

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  3 in total

1.  Liquid Biopsy-Based Biomarkers of Inflammatory Nociception Identified in Male Rats.

Authors:  Christina R Merritt; Irma E Cisneros; Obdulia Covarrubias-Zambrano; Sonja J Stutz; Massoud Motamedi; Stefan H Bossmann; Kathryn A Cunningham
Journal:  Front Pharmacol       Date:  2022-06-27       Impact factor: 5.988

Review 2.  Interleukin-17 as a potential therapeutic target for chronic pain.

Authors:  Xiaojuan Jiang; Ruihao Zhou; Yujun Zhang; Tao Zhu; Qian Li; Weiyi Zhang
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

3.  Interactions Among Non-Coding RNAs and mRNAs in the Trigeminal Ganglion Associated with Neuropathic Pain.

Authors:  Fei Liu; Jie-Fei Shen; Zhong-Han Fang; Hong-Lin Liao; Qing-Feng Tang; Ya-Jing Liu; Yan-Yan Zhang; Jiu Lin; Hao-Peng Yu; Cheng Zhou; Chun-Jie Li
Journal:  J Pain Res       Date:  2022-09-22       Impact factor: 2.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.